Skip to Main Content

Author Details

Virginia M-Y Lee
Perelman School of Medicine at the University of Pennsylvania
1977
937
186
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36824782Distinct biological activity of Lewy body α-Synuclein strain in mice.Res Sq2023
37703352A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury.Sci Transl Med2023
37745431Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.bioRxiv2023
37651366A Novel Brain PET Radiotracer for Imaging Alpha Synuclein Fibrils in Multiple System Atrophy.J Med Chem2023
37499037TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.Science2023
37814027Author Correction: Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.Nat Neurosci2023
37425910Genome-wide association study identifies a new susceptibility locus in <i>PLA2G4C</i> for Multiple System Atrophy.medRxiv2023
37150879Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.Brain2023
37248338Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage.Nat Neurosci2023
36945566O-GlcNAc modification forces the formation of an α-Synuclein amyloid-strain with notably diminished seeding activity and pathology.bioRxiv2023
37169750Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.NPJ Parkinsons Dis2023
37269953Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model.J Biol Chem2023
36809847Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD.Neurobiol Dis2023
36399276In Vitro Amplification of Pathogenic Tau Seeds from Neurodegenerative Disease Patient Brains.Methods Mol Biol2023
36778217Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.medRxiv2023
36534051Microtubule-Stabilizing 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and Computational Studies Reveal New Structure-Activity Insights.J Med Chem2023
36456471Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP-43 inclusions and ageing-related tau astrogliopathy in a family with a GBE1 mutation.Neuropathol Appl Neurobiol2023
36864661Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.Brain2023
35292638Tau deposition patterns are associated with functional connectivity in primary tauopathies.Nat Commun2022
35727707Investigating key factors underlying neurodegeneration linked to alpha-synuclein spread.Neuropathol Appl Neurobiol2022
35568882Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis.Acta Neuropathol Commun2022
35624093Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles.Nat Commun2022
37250748Cerebrovascular disease lesions are additive and tied to vascular risk factors and cognitive impairment.Free Neuropathol2022
36408394Manipulation of the diet-microbiota-brain axis in Alzheimer's disease.Front Neurosci2022
36540894Evaluation of blood-based, extracellular vesicles as biomarkers for aging-related TDP-43 pathology.Alzheimers Dement (Amst)2022
35258081Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease.Brain2022
35256815Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue.Nat Biotechnol2022
35131527Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology.Curr Opin Neurobiol2022
34854996Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.Acta Neuropathol2022
35246269Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization.Acta Neuropathol Commun2022
35063084Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.Cell2022
33091110α-Synuclein modulates tau spreading in mouse brains.J Exp Med2021
33644757Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.Brain Commun2021
33842063Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.Neurol Clin Pract2021
33720852LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons.J Parkinsons Dis2021
34851693AD-linked R47H-<i>TREM2</i> mutation induces disease-enhancing microglial states via AKT hyperactivation.Sci Transl Med2021
34412701Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery.Acta Neuropathol Commun2021
34819159Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro.Acta Neuropathol Commun2021
34503586Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.Acta Neuropathol Commun2021
34220490Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples.Front Aging Neurosci2021
34152475TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.Acta Neuropathol2021
34108219Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor.Sci Adv2021
33971027Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo.Neuropathol Appl Neurobiol2021
33449993The development and convergence of co-pathologies in Alzheimer's disease.Brain2021
33125873High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.Neuron2021
33385254In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.Acta Neuropathol2021
33411523Evaluation of the Structure-Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidines Identifies New Candidates for Neurodegenerative Tauopathies.J Med Chem2021
32317958Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia.Front Aging Neurosci2020
31999351Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.J Neuropathol Exp Neurol2020
31899072Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult.Neuron2020
  • 1 - 50 of 937

Recommended Authors

College of Medicine, University of Florida
Career Start Year 2014
Number of shared co-authors 3
University College London, UK Dementia Research Institute
Career Start Year 2013
Number of shared co-authors 13
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2011
Number of shared co-authors 5
University of Washington
Career Start Year 2011
Number of shared co-authors 13
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2010
Number of shared co-authors 6
David Geffen School of Medicine, University of California los angeles
Career Start Year 2007
Number of shared co-authors 26
College of Medicine, University of Florida
Career Start Year 2006
Number of shared co-authors 6
Eli Lilly & Co.
Career Start Year 2006
Number of shared co-authors 12
Center for Translational Research in Neurodegenerative Disease, University of Florida
Career Start Year 2006
Number of shared co-authors 74
University of California davis
Career Start Year 2005
Number of shared co-authors 31
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 4
Emory University School of Medicine
Career Start Year 2001
Number of shared co-authors 19
Institute for Neurodegenerative Diseases, University of California san francisco
Career Start Year 2000
Number of shared co-authors 4
Center for Translational Research in Neurodegenerative Disease, University of Florida
Career Start Year 2000
Number of shared co-authors 84
Institute of Basic Medical Sciences, University of Oslo
Career Start Year 1999
Number of shared co-authors 3
University of California, San Diego and VA San Diego Healthcare System (D.G.
Career Start Year 1998
Number of shared co-authors 6
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 13
Roche Pharma Research and Early Development (pRED)
Career Start Year 1996
Number of shared co-authors 2
University of Washington
Career Start Year 1995
Number of shared co-authors 63
Mannheim Center for Translational Neuroscience, Heidelberg University
Career Start Year 1995
Number of shared co-authors 6
Stanford University
Career Start Year 1992
Number of shared co-authors 38
UCL Queen Square Institute of Neurology
Career Start Year 1989
Number of shared co-authors 9
University of Washington School of Medicine
Career Start Year 1988
Number of shared co-authors 10
Rush University Medical Center
Career Start Year 1983
Number of shared co-authors 14
University of Kentucky
Career Start Year 1982
Number of shared co-authors 5
Duke University Medical Center
Career Start Year 1981
Number of shared co-authors 4
German Center for Neurodegenerative Diseases (DZNE) Munich
Career Start Year 1981
Number of shared co-authors 32
Inc. University Avenue
Career Start Year 1980
Number of shared co-authors 15
University of Arkansas for Medical Sciences
Career Start Year 1975
Number of shared co-authors 6
College of Sciences, The University of Texas at San Antonio
Career Start Year 1970
Number of shared co-authors 30

Collaborators

University of Pennsylvania
Co-authored papers 706
Massachusetts General Hospital
Co-authored papers 50
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 35
Co-authored papers 32
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 28
University of Pennsylvania
Co-authored papers 22
Co-authored papers 20
University of Pennsylvania
Co-authored papers 19
Co-authored papers 18
Mayo Clinic Jacksonville
Co-authored papers 18
University of Washington School of Medicine
Co-authored papers 15
Co-authored papers 15
Lou Ruvo Center for Brain Health, Cleveland Clinic
Co-authored papers 14
Stanford University
Co-authored papers 14
Comprehensive Center for Brain Health, University of Miami Miller School of Medicine
Co-authored papers 13
Washington University School of Medicine
Co-authored papers 13
National Institute On Aging
Co-authored papers 12
Mayo Clinic Rochester
Co-authored papers 12
University of Pennsylvania Perelman School of Medicine
Co-authored papers 11
Co-authored papers 10
Massachusetts General Hospital
Co-authored papers 9
Washington University School of Medicine
Co-authored papers 8
Uniformed Services University School of Medicine
Co-authored papers 8
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Mayo Clinic Rochester
Co-authored papers 8
Oregon Center for Aging & Technology
Co-authored papers 7
Stanford University School of Medicine
Co-authored papers 7
University of California San Diego
Co-authored papers 7
University of California Davis
Co-authored papers 7
Mayo Clinic Florida
Co-authored papers 7